Analyst consensus rating
Syndax Pharmaceuticals Analyst Rating: Strong Buy
Direct answer
Syndax Pharmaceuticals's consensus rating is Strong Buy.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $37.27.
Forecast evidence checked October 17, 2026.
Get free Syndax Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $12.90
- Average price target
- $37.27
- High price target
- $57.00
- Low price target
- $23.00
- Low target gap
- +78.3%
- Target upside
- +188.9%
- High target gap
- +341.9%
- Target range width
- 263.6%
- Consensus rating
- Strong Buy
- Analysts
- 11
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Syndax Pharmaceuticals?
Syndax Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $37.27.
How far are Syndax Pharmaceuticals's low and high targets from the recorded price?
The low target implies +78.3%, while the high target implies +341.9%.
How many analysts are included in Syndax Pharmaceuticals's consensus?
The verified consensus includes 11 analysts.
How is Syndax Pharmaceuticals's target upside or downside calculated?
The average target of $37.27 is divided by the recorded price of $12.90, then one is subtracted to produce +188.9%. This does not guarantee a future return.
When was Syndax Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.